BVS vs CB · rev $573.3M vs P/E 14, rev $59.40B
Bioventus Inc (BVS) versus Chubb Ltd (CB) — a side-by-side from cached financials, not a winner call.
Bioventus Inc (BVS) is a medical devices company listed on US.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Latest reported BVS revenue for 2024-12-31 was $573.3M. Net income was -$43.8M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. BVS currently screens at market cap $495.1M.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
BVS currently screens at market cap $495.1M. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Not investment advice. Open the BVS and CB stock pages for the full models.
Not investment advice.